Abstract
This study investigated the effects of treatment with acamprosate on craving for alcohol by using a contextual priming task with alcohol and neutral words and craving questionnaires (ACQ, OCDS) in alcohol-dependent patients who abstained from alcohol for 6 weeks. The acamprosate-treated group (n = 16) were given 666 mg t.d.s. with standard group-work aimed at abstinence. The unmedicated control group (n = 13) received only standard group therapy. The results showed that the acamprosate treated group was faster in their responses to craving-related stimuli and scored lower on craving questionnaires during week 6 compared with week 2. Our results suggest that acamprosate may play a role in reduction of craving for alcohol after 6 weeks of treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 229-232 |
| Number of pages | 4 |
| Journal | Addiction Biology |
| Volume | 8 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2003 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver